Related Experiment Video
Updated: Aug 13, 2026

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus
Published on: June 2, 2023
Factor VIIa inhibitors: gaining selectivity within the trypsin family
William D Shrader1, Aleksandr Kolesnikov, Jana Burgess-Henry
1Celera Genomics, 180 Kimball Way, South San Francisco, CA 94080, USA. bill.shrader@celera.com
Abstract:
Within the trypsin family of coagulation proteases, obtaining highly selective inhibitors of factor VIIa has been challenging. We report a series of factor VIIa (fVIIa) inhibitors based on the 5-amidino-2-(2-hydroxy-biphenyl-3-yl)-benzimidazole (1) scaffold with potency for fVIIa and high selectivity against factors IIa, Xa, and trypsin. With this scaffold class, we propose that a unique hydrogen bond interaction between a hydroxyl on the distal ring of the biaryl system and the backbone carbonyl of fVIIa lysine-192 provides a basis for enhanced selectivity and potency for fVIIa.
More Related Videos
09:47The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
Published on: May 25, 2018
19:23Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
Published on: January 16, 2019
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Enzyme Inhibition
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: